Genotype, n (%) | Allele Test | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CHR | SNP | Locus | 1/2 | Subgroup (n) | 1/1 | 1/2 | 2/2 | MAF, % | p* | pFDR** | OR (95% CI)*** |
7 | rs2069827 | IL6 | G/T | Controls (289) | 226 (78.20) | 57 (19.72) | 6 (2.08) | 11.94 | |||
SSc (579) | 466 (80.48) | 107 (18.48) | 6 (1.04) | 10.28 | 0.29 | 0.44 | 0.84 (0.62–1.16) | ||||
lcSSc (338) | 267 (78.99) | 67 (19.82) | 4 (1.18) | 11.09 | 0.64 | 0.90 | 0.92 (0.65–1.30) | ||||
dcSSc (241) | 199 (82.57) | 40 (16.60) | 2 (0.83) | 9.13 | 0.14 | 0.21 | 0.74 (0.50–1.11) | ||||
ACA+ (224) | 182 (81.25) | 39 (17.41) | 3 (1.34) | 10.04 | 0.34 | 0.51 | 0.82 (0.55–1.23) | ||||
ATA+ (190) | 154 (81.05) | 35 (18.42) | 1 (0.53) | 9.74 | 0.29 | 0.43 | 0.80 (0.52–1.21) | ||||
7 | rs1800795 | IL6 | G/C | Controls (290) | 83 (28.62) | 148 (51.03) | 59 (20.34) | 45.86 | |||
SSc (568) | 205 (36.09) | 262 (46.13) | 101 (17.78) | 40.85 | 0.05 | 0.14 | 0.82 (0.67–1.00) | ||||
lcSSc (331) | 112 (33.84) | 158 (47.73) | 61 (18.43) | 42.30 | 0.21 | 0.62 | 0.87 (0.69–1.08) | ||||
dcSSc (237) | 93 (39.24) | 104 (43.88) | 40 (16.88) | 38.82 | 0.02 | 0.06 | 0.75 (0.59–0.96) | ||||
ACA+ (219) | 79 (36.07) | 105 (47.95) | 35 (15.98) | 39.95 | 0.06 | 0.18 | 0.79 (0.61–1.01) | ||||
ATA+ (189) | 75 (39.68) | 81 (42.86) | 33 (17.46) | 38.89 | 0.03 | 0.10 | 0.75 (0.58–0.98) | ||||
7 | rs2069840 | IL6 | C/G | Controls (287) | 125 (43.55) | 136 (47.39) | 26 (9.06) | 32.75 | |||
SSc (572) | 254 (44.41) | 251 (43.88) | 67 (11.71) | 33.65 | 0.71 | 0.71 | 1.04 (0.84–1.29) | ||||
lcSSc (334) | 149 (44.61) | 149 (44.61) | 36 (10.78) | 33.08 | 0.90 | 0.90 | 1.02 (0.80–1.29) | ||||
dcSSc (238) | 105 (44.12) | 102 (42.86) | 31 (13.03) | 34.45 | 0.56 | 0.56 | 1.08 (0.83–1.40) | ||||
ACA+ (220) | 90 (40.91) | 109 (49.55) | 21 (9.55) | 34.32 | 0.60 | 0.60 | 1.07 (0.82–1.40) | ||||
ATA+ (189) | 84 (44.44) | 78 (41.27) | 27 (14.29) | 34.92 | 0.49 | 0.49 | 1.10 (0.84–1.45) |